Ironwood Pharmaceuticals (IRWD) Return on Capital Employed Growth (3y) (2014 - 2026)
Ironwood Pharmaceuticals (IRWD) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | 1,301.00 |
| 3 | Zoetis | 32.72 Bn | 30.78 Bn | 1.62 Bn | 331.00 |
| 4 | Takeda Pharmaceutical | 27.65 Bn | 23.59 Bn | 4.39 Bn | -667.00 |
| 5 | United Therapeutics | 23.11 Bn | 20.96 Bn | 648.10 Mn | 480.00 |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn | -254.00 |
| 8 | Neurocrine Biosciences | 17.88 Bn | 16.56 Bn | 800.70 Mn | 1,342.00 |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 1,902.00 |
| 10 | Ironwood Pharmaceuticals | 643.18 Mn | 422.71 Mn | - | 8,869.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,869.00 |
| Dec 31, 2025 | 3,990.00 |
| Sep 30, 2025 | 7,268.00 |
| Jun 30, 2025 | 4,813.00 |
| Mar 31, 2025 | -734.00 |
| Dec 31, 2024 | 343.00 |
| Sep 30, 2024 | 362.00 |
| Jun 30, 2024 | -46.00 |
| Mar 31, 2024 | -52,262.00 |
| Dec 31, 2023 | -45,585.00 |
| Sep 30, 2023 | -35,557.00 |
| Jun 30, 2023 | -19,508.00 |
| Mar 31, 2023 | -1,711.00 |
| Dec 31, 2022 | -1,271.00 |
| Sep 30, 2022 | -1,256.00 |
| Jun 30, 2022 | 7,237.00 |
| Mar 31, 2022 | 9,026.00 |
| Dec 31, 2021 | 9,031.00 |
| Sep 30, 2021 | 5,304.00 |
| Jun 30, 2021 | 2,806.00 |